Notification
Biden-Harris Administration Announces Medicare Advantage and Medicare Part D Prescription Drug Proposals that Aim to Improve Care and Access for Enro
- [登録者]Centers for Medicare & Medicaid Services (CMS)
- [言語]日本語
- [エリア]Baltimore, MD
- 登録日 : 2024/11/26
- 掲載日 : 2024/11/26
- 変更日 : 2024/11/26
- 総閲覧数 : 42 人
- お店を検索するなら『タウンガイド』
-
- 新学期于2月4日开始 ! ・ 请注意 : 华盛顿特区没有学校 SAPIX USA...
-
您可以在美国 ! 参加这些 "SAPIX "课程,而且 ! 您可以在大华盛顿特区参加 "SAPIX 美国 "课程,这与日本的 SAPIX 不同 ! 进入日本 ・。关于入学考试,请交给 SAPIX! 您可以在纽约、新泽西、曼哈顿和圣何塞的学校进行在线学习 ! 请注意 : 华盛顿特区没有校舍。可提供纽约学校和其他在线课程。 电话号码是纽约学校的。咨询由纽约学校处理。 随时欢迎新学生 ...
+1 (914) 358-5337SAPIX USA
-
- 它是一个非营利性组织,将全美讲日语的医疗保健专业人员和患者联系在一起,并为日本社...
-
FLAT ・ FLAT是一个非营利性组织,总部设在纽约市,业务遍及全美,为讲日语的医疗保健专业人员和患者牵线搭桥,并为日本社区提供支持。 随着越来越多的日本人及其照顾者在美国面临复杂的医疗保健和保险问题,随着越来越多的老年人随着年龄的增长而变得孤立无援,我们为他们提供所需的信息和支持。 我们还在网上积极开展活动,并向居住在纽约以外的人开放。 我们致力于通过与健康相关的计划满足您的需求,请...
+1 (772) 349-9459FLAT ・ふらっと
-
- 华盛顿特区 ・ 弗吉尼亚州 ・ 马里兰州 ・ 康涅狄格州 家庭医生。请随时用日语...
-
对于那些离开日本到美国生活的人来说,最担心和最重要的事情就是自己和家人的健康。我们的诊所位于新泽西州,提供全方位的医疗服务,包括内科、儿科、外科、妇科、皮肤科、眼科和耳鼻喉科。除新泽西州外,希巴里家庭医疗中心现已在华盛顿特区、弗吉尼亚州、马里兰州和康涅狄格州推出远程会诊服务。即使您居住在偏远地区,我们也能为儿童和老人提供日语医疗服务。
+1 (201) 581-8553ひばりファミリーメディカル
-
- 精神病学 ・ 欢迎来到心身医学家松木隆医生的华盛顿特区办公室 我们为整个华盛顿特...
-
他们中的许多人面临着各种压力,例如对外国的不熟悉、对新工作或新学校的不适应、文化和语言障碍以及与日本家人和朋友的分离。高度的压力会导致各种精神障碍。 您是否有这些症状 ? 情绪低落、疲劳、倦怠、失去乐趣、失去兴趣、孤独、易怒、内疚、空虚、食欲不振、食欲增加、焦虑、恐慌、恐惧症、压力、易怒、感觉模糊、愤怒、失眠、嗜睡、噩梦、注意力不集中、心烦意乱、坐立不安、失落、悲伤、厌食、暴饮暴食、头晕、麻...
+1 (201) 809-3508精神科・心療内科医 松木隆志
Centers for Medicare & Medicaid ServicesNewsroom
FOR IMMEDIATE RELEASE
November 26, 2024
Contact: CMS Media Relations
CMS Media Inquiries [ https://www.cms.gov/About-CMS/Public-Affairs/PressContacts/Media-inquiries1.html ]
________________________________________________________________________
*Biden-Harris Administration Announces Medicare Advantage and Medicare Part D Prescription Drug Proposals that Aim to Improve Care and Access for Enrollees*
"Proposed Rule Would Expand Access to Anti-Obesity Medications and Builds on Previous Policies to Improve Enrollee Protections and Competition"
* *Today, the Centers for Medicare & Medicaid Services (CMS) is proposing actions in the Medicare Advantage (MA) and Medicare Part D prescription drug programs to continue to strengthen protections and access to care for people with Medicare. The Contract Year (CY) 2026 MA and Part D proposed rule aims to hold MA and Part D plans more accountable for delivering high-quality coverage so that people with Medicare are connected to the care they need when they need it. In recognition of the prevailing medical consensus that obesity is a disease, CMS is proposing to reinterpret the statute to no longer exclude anti-obesity medications for the treatment of obesity from coverage under Medicare Part D and to require Medicaid programs to cover these medications when used to treat obesity. This proposal would provide more Americans access to these transformative medications, improving the health and quality of life for millions of people who have obesity.
This proposed rule continues the Biden-Harris Administration’s work to ensure the MA and Part D programs meet the needs of people with Medicare. In recent years, there have been increasing calls for reforms related to MA prior authorization, utilization management, and coverage decisions. CMS remains concerned about barriers to accessing care and high burden on the system. For example, data reported to CMS by MA plans indicate that, on average, MA plans overturn 80% of their decisions to deny claims when those claims are appealed to the plan. These data also show that less than 4% of denied claims are appealed in the first place, meaning many more denials could potentially be overturned by the plan if they were appealed. Ultimately, what these and other data show is that MA enrollees may not be getting access to the care they need. The proposed rule builds on CMS’ work to remove unnecessary barriers to care resulting from the inappropriate use of prior authorization and internal coverage criteria. The rule would also increase guardrails on the use of artificial intelligence (AI) to protect access to health services. Other proposed policies will promote competition on the things that matter to people enrolled in MA and Part D plans, further addressing misleading marketing practices, and enhancing consumer tools on Medicare.gov.
“Our loved ones with Medicare deserve care that puts their interests first. HHS is proposing to improve transparency, accountability, and consumer protections in Medicare Advantage and Part D plans so that everyone receives high-quality care,” said HHS Secretary Xavier Becerra. “To achieve that, we want to remove barriers that delay care or deny people services and medications they need to be healthy. In addition, we continue to promote competition for pharmacies and other health care businesses.”
“The Biden-Harris Administration has worked to ensure that the Medicare Advantage and Part D prescription drug programs work for people with Medicare, adopted policies holding plans accountable for providing high-quality health care, and protected the sustainability of the Medicare program,” said CMS Administrator Chiquita Brooks-LaSure. “This proposed rule continues to build on this work by expanding access to anti-obesity medications for people with Medicare and Medicaid, further addressing prior authorization concerns in Medicare Advantage, and promoting informed choice and transparency by requiring Medicare Advantage plans to share provider directory information on Medicare Plan Finder.”
Over the past few years, CMS has made improvements to Medicare Plan Finder [ https://www.medicare.gov/plan-compare/#/?year=2024&lang=en ] based on research and feedback from the public. CMS has enhanced Medicare Plan Finder’s capabilities as an online tool that helps people with Medicare to compare Medicare options, including shopping for MA and Part D plans and comparing to Traditional Medicare. In this proposed rule, CMS is further proposing to enhance Medicare Plan Finder’s ability to provide a personalized experience for people with Medicare and their caregivers by proposing that MA organizations make their entire provider directory available to CMS, for the purpose of incorporating it into Medicare Plan Finder. This would enable people with Medicare and their caregivers to search for providers and more easily compare their availability across different MA plans.
“We continue to hear from people enrolled in Medicare Advantage who are having difficulty accessing the care they need and are entitled to, and CMS remains focused on removing these barriers,” said Meena Seshamani, MD, PhD, CMS Deputy Administrator and Director of the Center for Medicare. “Whether it’s difficulty navigating options, being able to afford the lifesaving medications you are prescribed by your doctor, or receiving the inpatient or rehabilitation care you need to get well, no senior or person with disabilities on Medicare should be having these challenges.”
CMS is also addressing competition in the MA and Part D programs in this proposed rule. In line with the Biden-Harris Administration’s focus on promoting competition for consumers in health care, CMS is proposing to update the MA and Part D Medical Loss Ratio (MLR) regulations to improve the data reported by plans. CMS is seeking comment on policies regarding how the MA and Part D MLRs are calculated to help enable policymakers to address concerns surrounding vertical integration in MA organizations and Part D sponsors. In addition, CMS is taking steps to promote transparency for pharmacies.
Additionally, CMS is strengthening consumer protections by proposing changes to expand CMS oversight of MA advertisements, which would build on previously finalized policies to protect people with Medicare from predatory behavior, such as misleading television, web-based, and direct mail advertisements. Since 2023, CMS has issued denials for over 1,500 TV ad submissions that were non-compliant and misleading to consumers. CMS is also improving the proper administration of MA supplemental benefits through debit cards, better ensuring that CMS is a good steward of MA rebate dollars used for supplemental benefits and premium buy-downs, which, according to the Medicare Trustees, are estimated to amount to over $79 billion in 2026 and amount to approximately $500 billion over a 5-year period starting in 2026.
To review or comment on the CY 2026 MA and Part D proposed rule during its 60-day public comment period, visit the Federal Register [ https://www.federalregister.gov/public-inspection/2024-27939/medicare-and-medicaid-programs-contract-year-2026-policy-and-technical-changes-to-the-medicare ]. Comments must be submitted no later than January 27, 2025.
For more information on the CY 2026 MA and Part D proposed rule, view the fact sheet [ https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription ].
###
Get CMS news at cms.gov/newsroom [ http://link.email.dynect.net/link.php?DynEngagement=true&H=WAA0HYy4enWklLGLVOCoftvRiKxkwcx7028A%2BNZlWSzSEaUD3cyAX035GTwXuYTIXFDieu0AW3NISgPnFlGO8TxKNlBMRZHoDOZ%2F7FoGDJBjgSzNyRQV4ZXQuHXfeyeK&G=0&R=https%3A%2F%2Fwww.cms.gov%2FNewsroom%2FNewsroom-Center.html&I=20171205171347.00000283d32a%40mail6-33-usnbn1&X=MHwxMDQ2NzU4OjVhMjZkM2FjZGNhM2QwMGY5NmZmNjA2Mjs%3D&S=F4PFefpCWAIXfcE1-foA4aF3Z5qzU2JMir53nncUzAk ], sign up for CMS news via email [ http://link.email.dynect.net/link.php?DynEngagement=true&H=WAA0HYy4enWklLGLVOCoftvRiKxkwcx7028A%2BNZlWSzSEaUD3cyAX035GTwXuYTIXFDieu0AW3NISgPnFlGO8TxKNlBMRZHoDOZ%2F7FoGDJBjgSzNyRQV4ZXQuHXfeyeK&G=0&R=https%3A%2F%2Fpublic.govdelivery.com%2Faccounts%2FUSCMS%2Fsubscriber%2Fnew%3Ftopic_id%3DUSCMS_610&I=20171205171347.00000283d32a%40mail6-33-usnbn1&X=MHwxMDQ2NzU4OjVhMjZkM2FjZGNhM2QwMGY5NmZmNjA2Mjs%3D&S=yKSYEB9wWjKz90OM4j3cpWtIMUGdYgLHhDQ4a8cDXTM ] and follow CMS on X (Formerly Twitter) @CMSgov [ http://link.email.dynect.net/link.php?DynEngagement=true&H=WAA0HYy4enWklLGLVOCoftvRiKxkwcx7028A%2BNZlWSzSEaUD3cyAX035GTwXuYTIXFDieu0AW3NISgPnFlGO8TxKNlBMRZHoDOZ%2F7FoGDJBjgSzNyRQV4ZXQuHXfeyeK&G=0&R=https%3A%2F%2Ftwitter.com%2FCMSGov&I=20171205171347.00000283d32a%40mail6-33-usnbn1&X=MHwxMDQ2NzU4OjVhMjZkM2FjZGNhM2QwMGY5NmZmNjA2Mjs%3D&S=QzuR5f2SC_PCPUiFWOvDtEQwzu5IQetkxhE4vLzn2xo ]
Newsroom
________________________________________________________________________
You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].
This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].
________________________________________________________________________
This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244
body .abe-column-block { min-height: 5px; } table.gd_combo_table img {margin-left:10px; margin-right:10px;} table.gd_combo_table div.govd_image_display img, table.gd_combo_table td.gd_combo_image_cell img {margin-left:0px; margin-right:0px;} table.govd_hr {min-width: 100%;}